Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Novartis (NVS)

Novartis AG

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:NVS

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
18/11/2024	13:00	PR Newswire (US)	Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate	NYSE:NVS	Novartis AG
04/11/2024	11:20	IH Market News	Tesla Sales Drop; Intel to Exit Dow Jones After 25 Years; VKTX and ATSG Surge Over 20% Pre-Market	NYSE:NVS	Novartis AG
29/10/2024	20:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVS	Novartis AG
29/10/2024	10:20	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVS	Novartis AG
29/10/2024	09:39	IH Market News	HSBC Reports $8.5 Billion Profit; Boot Barn Announces New CEO and Projections; TMDX Drops 24%, VFC Surges 22%	NYSE:NVS	Novartis AG
18/10/2024	10:53	PR Newswire (US)	Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer	NYSE:NVS	Novartis AG
17/10/2024	20:01	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NYSE:NVS	Novartis AG
03/10/2024	12:45	InvestorsHub NewsWire	Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More	NYSE:NVS	Novartis AG
16/09/2024	12:44	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:NVS	Novartis AG
16/09/2024	12:12	Edgar (US Regulatory)	Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NYSE:NVS	Novartis AG
16/09/2024	10:03	IH Market News	Intel Secures $3.5 Billion Subsidy, Stellantis Backs EU Emissions Targets, BP and Apollo Reach $1 Billion Deal	NYSE:NVS	Novartis AG
10/09/2024	22:53	AllPennyStocks.com	Junior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving Lives	NYSE:NVS	Novartis AG
05/09/2024	12:00	GlobeNewswire Inc.	Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14	NYSE:NVS	Novartis AG
28/08/2024	16:16	Business Wire	Lindy Biosciences stringe un accordo di licenza e collaborazione con Novartis per la somministrazione innovativa di farmaci multitarget	NYSE:NVS	Novartis AG
28/08/2024	16:07	Business Wire	Lindy Biosciences conclut un accord de licence et de collaboration avec Novartis pour l’innovation en matière d’administration de médicaments à cibles multiples	NYSE:NVS	Novartis AG
28/08/2024	16:06	Business Wire	Lindy Biosciences schließt Lizenzierungs- und Kooperationsvereinbarung mit Novartis für Wirkstoffabgabeinnovation für mehrere Zielmoleküle ab	NYSE:NVS	Novartis AG
28/08/2024	10:58	Business Wire	Lindy Biosciences Enters Licensing and Collaboration Agreement With Novartis for Multi-target Drug Delivery Innovation	NYSE:NVS	Novartis AG
26/08/2024	12:58	IH Market News	IBM Closes China Research Division, Uber Fined $324M, Starliner to Return Without Astronauts	NYSE:NVS	Novartis AG
15/08/2024	20:30	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NYSE:NVS	Novartis AG
13/08/2024	20:31	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NYSE:NVS	Novartis AG
12/08/2024	19:30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:NVS	Novartis AG
07/08/2024	23:38	PR Newswire (US)	Novartis receives FDA accelerated approval for Fabhalta® (iptacopan), the first and only complement inhibitor for the reduction of proteinuria in primary IgA nephropathy (IgAN)	NYSE:NVS	Novartis AG
06/08/2024	09:44	IH Market News	Google Faces Antitrust Ruling; SunPower Files for Bankruptcy and Business Sale – Latest Business News	NYSE:NVS	Novartis AG
02/08/2024	20:30	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NYSE:NVS	Novartis AG
01/08/2024	20:30	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NYSE:NVS	Novartis AG
31/07/2024	20:30	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NYSE:NVS	Novartis AG
30/07/2024	20:30	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NYSE:NVS	Novartis AG
30/07/2024	11:00	GlobeNewswire Inc.	Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update	NYSE:NVS	Novartis AG
29/07/2024	20:30	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NYSE:NVS	Novartis AG
25/07/2024	20:30	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NYSE:NVS	Novartis AG

Showing the most relevant articles for your search:NYSE:NVS

1 2 3 4 5 6 7 8 9 10 Next >>

Diversified Energy

Supply@me Capital

Liontrust Asset Management

Shield Therapeutics

Anglo Asian Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions